TP53 and breast cancer: We showed further that while p53 tumor suppressor is dispensable for BITC-induced apoptosis, this chemopreventive agent is capable of suppressing oncogenic actions of leptin through inhibition of signal transducer and activator of transcription 3 in human breast cancer cells [15], [16].